ClinicalTrials.Veeva

Menu

The Efficacy and Safety of Disposable Balloon Uterine Stent in Patients With Asherman Syndrome

B

Beijing Obstetrics and Gynecology Hospital

Status

Unknown

Conditions

Intrauterine Adhesion

Treatments

Device: disposable balloon uterine stent
Device: Foley catheter

Study type

Interventional

Funder types

Other

Identifiers

NCT03330873
No.3-20140601

Details and patient eligibility

About

Asherman's syndrome is characterized by the presence of intrauterine adhesions (IUA) as well as symptoms such as amenorrhea, hypomenorrhea, pelvic pain, and infertility. The gold standard for the treatment of intrauterine adhesions is hysteroscopic intrauterine adhesions. The recurrence of intrauterine adhesions is a major challenge in clinical practice. The isolation of barriers in the uterine cavity may be a measure to reduce postoperative re adhesion, but the effect of different devices is different. Therefore, this study was conducted.

Full description

The Foley catheter is usually inserted into the uterine after a hysteroscopic adhesiolysis and removed after on the 5-7th day after surgery. Several investigators demonstrated its favorable effect in the recurrence of adhesion after the treatment of intrauterine adhesion. Disposable balloon uterine stent is specially designed to fit into the cavity of the uterus, and usually removed on the 7th day after surgery.

Enrollment

80 estimated patients

Sex

Female

Ages

20 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age 20-40 years;
  • Moderate to severe intrauterine adhesion (AFS score ≥5);
  • complains of menstruation disorder and reproductive dysfunction
  • Agreement to have second-look hysteroscopy
  • informed consent

Exclusion criteria

  • ovarian failure
  • patients who did not proceed to second-look hysteroscopy within the specified time frame
  • Contraindication of hormone

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

80 participants in 2 patient groups

Foley catheter
Experimental group
Description:
After the completion of hysteroscopic adhesiolysis, Foley catheter was inserted and inflated with normal saline which was removed on the 7th day after surgery.
Treatment:
Device: Foley catheter
Disposable balloon uterine stent
Experimental group
Description:
After the completion of hysteroscopic adhesiolysis, disposable balloon uterine stent was inserted and inflated with normal saline which was removed on the 7th day after surgery.
Treatment:
Device: disposable balloon uterine stent

Trial contacts and locations

1

Loading...

Central trial contact

Zhu Ru, MD; Wang Sha, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems